Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-28T00:41:35.976Z Has data issue: false hasContentIssue false

Cholera, Travel, and Infection Control

Published online by Cambridge University Press:  21 June 2016

Mary D. Nettleman*
Affiliation:
Department of Medicine, the Division of General Medicine, Clinical Epidemiology and Health Services Research, The University of Iowa Hospitals and Clinics, Iowa City, Iowa

Extract

Recent outbreaks of cholera in South America and a handful of imported cases in the United States have transformed the disease from a third-world curiosity to an important issue for our daily American newspapers. Although cholera often is considered one of the classic plagues of humankind, we now know that the disease can be contained with modern sanitation and that, with proper hydration, mortality rates are less than 1%. The role of epidemiologists and infection control practitioners should be to provide information, reassure the public, and prevent harmful attempts at infection control based on “cholera hysteria.”

It is surprising to realize that cholera is a relative newcomer to the global pestilence scene. In fact, pandemics were not reported before the 18th century..’ As cholera spread from Asia to Europe, panic outran the disease and was exacerbated by futile attempts to limit the epidemic. Cholera victims were placed in strict quarantine, and their houses were burned. In some instances, military troops encircled towns or fortified borders in a vain attempt to confine the disease. Public officials would deny that cholera had invaded their cities until the graveyards were filled with indisputable evidence. In the early 1800s, during the height of the epidemic in the United States, 1,000 people died daily in Philadelphia, Pennsylvania, alone.2 Virtually all those deaths could have been prevented with proper rehydration and replacement of electrolytes.

Type
Emporiatrics
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1991

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Selwyn, S. Cholera old and new. Proc Roy Soc Med. 1977;70:301310.Google Scholar
2. Keusch, GT. Why cholera may be important to doctors in the US. Medical Times. 1971;99:8694.Google Scholar
3. Mukerjee, S, Basu, S, Bhattacharya, l? A new trend in cholera epidemiology. Br Med J. 1965;2:837839.Google Scholar
4. Centers for Disease Control. Cholera-worldwide. 1989. MMWR. 1990;39:365367.Google Scholar
5. Centers for Disease Control. Update: cholera outbreak-Peru, Ecuador, and Columbia. MMWR. 1991;40:225227.Google Scholar
6. Public Health Service. Cholera—South America. Advisory Memorandum No. 98;1991.Google Scholar
7. U.S. Department of Health and Human Services. Health information for international travel. 1990. HHS Publication No. (CDC) 90-8280:146.Google Scholar
8. Hot-nick, RB, Music, SI, Wenzel, R, et al. The broad street pump revisited: response of volunteers to ingested cholera vibrios. Bull NY Acad Med. 1971;47:11811191.Google Scholar
9. Cash, R, Music, S, Libonati, J, Snyder, M, Wenzel, R, Hornick, B. Response of man to infection with V cholerae, I. Clinical, serologic, and bacteriologic responses to a known inoculum. J Infect Dis. 1974;129:4552.Google Scholar
10. Holmgren, J, Svennerholm, A-M. Mechanisms of disease and immunity in cholera: a review. J Infect Dis. 1977;136(suppl):S105sl12.CrossRefGoogle ScholarPubMed
11. Kabir, S, Ahmed, N, Ali, S. Neuraminidase production by Vibrio cholera 01 and other diarrhoeogenic bacteria. Infect Immunol. 1984;44:747749.Google Scholar
12. Gangarosa, EJ. The epidemiologic basis of cholera control. Pan American Health Organization Bulletin. 1974;8:189197.Google Scholar
13. Rabbani, GH. Cholera. Clin Gasteroenterol. 1986;15:507528.CrossRefGoogle ScholarPubMed
14. Carpenter, CC, Mahmoud, AA, Warren, KS. Algorithms in the diagnosis and management of exotic disease. XXVI. Cholera. J Infect Dis. 1977;136:461463.Google Scholar
15. Patra, CC, Mahalanabis, D, Jalan, KN, Sen, A, Banerjee, P. In search of a super solution: controlled trial of glycine-glucose oral rehydration solution in infantile diarrhoea. Acta Paediatr Scand. 1984;73:1821.CrossRefGoogle ScholarPubMed
16. Nalin, DR, Cash, RA, Rahman, M, Yunus, M. Effect of glycine and glucose on sodium and water absorption in patients with cholera. Gut. 1970;11:768772.Google Scholar
17. Bhattacharya, SK, Bhattacharya, MK, Dutta, P, et al. Double-blind, randomized, controlled clinical trial of norfloxacin for cholera. Antimicrob Agents Chemother. 1990;34:939940.Google Scholar
18. Finch, MJ, Morris, JG, Kaviti, J, Kagwanja, W, Levine, MM. Epidemiology of antimicrobial resistant cholera in Kenya and East Africa. Am I Trop Med Hyg. 1988;39:484490.Google Scholar
19. Cash, RA, Music, SI, Libonati, JP, Craig, JP, Pierce, NE, Hornick, RB. Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine. J Infect Dis. 1974;130:325333.CrossRefGoogle Scholar
20. Mall, T, Gyr, K. Episode resembling immune complex disease after cholera vaccination. Transact Roy Sac Trop Med Hygiene. 1984;78:106107.Google Scholar
21. Brahams, D. Damages for stroke after cholera and typhoid vaccination. Br I Clin Pract. 1985;ii:1372.Google Scholar
22. Gatt, DT. Pancreatitis following monovalent typhoid and cholera vaccinations. Br I Clin Pract. 1986:40:300301.Google Scholar
23. Mittermayer, CH. Lethal complications of typhoid-cholera vaccination: case report and review of the literature. Beitr Path Bd. 1976;158:212224.Google Scholar
24. Snyder, JD, Blake, PA. Is cholera a problem for US travelers? JAMA. 1982;247:22682269.Google Scholar
25. Centers for Disease Control. Cholera vaccine. MMWR. 1988;37:617619.Google Scholar
26. Felsenfeld, O, Wolf, RH, Gyr, K. Simultaneous vaccination against cholera and yellow fever. Lancet. 1973;i 457458.Google Scholar
27. Sommer, A, Mosley, W. Ineffectiveness of cholera vaccination as an epidemic control measure. Lancet, 1973;i 12311235.Google Scholar
28. Svennerholm, AM, Jertborn, M, Gothefors, L, Karim, AM, Sack, DA, Holmgren, J. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J Infect Dis. 1984;149:884893.CrossRefGoogle ScholarPubMed
29. Elliott, J. Vaccine for cholera and turista? JAMA. 1978;240:1330.Google Scholar
30. McCormack, WM, Chowdhury, AM, Jahangir, N, Ahmed, AB, Mosley, WH. Tetracycline prophylaxis in families of cholera patients. Bull WHO 1968;38:787792.Google ScholarPubMed
31. Gangarosa, EJ, Barker, WH. Cholera: implications for the United States. JAMA. 1974;227:170171.Google Scholar
32. Sommer, A, Khan, M, Mosley, WH. Efficacy of vaccination of family contacts of cholera cases. Lancet. 1973;i:12301231.Google Scholar